3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Unknown
3
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
17
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Surveys and Questionnaires
39
Blood Specimen Collection
23
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Magnetic Resonance Spectroscopy
10
Interviews as Topic
10
Observation
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mental Status and Dementia Tests
5
Mastectomy, Segmental
5
Immune Checkpoint Inhibitors
5
Biopsy
5
ribociclib
4
palbociclib
4
lorlatinib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Ipilimumab
4
High-Throughput Nucleotide Sequencing
4
Hepatectomy
4
Echocardiography
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
Crizotinib
×
Clear all
NCT03375242
2026-03-30
Safety and Efficacy of Xalkori ROS1
Pfizer
Active not recruiting
97 enrolled